These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2995568)

  • 21. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cholestatic liver diseases].
    Grimm D; Thimme R
    Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.
    Michieletti P; Wanless IR; Katz A; Scheuer PJ; Yeaman SJ; Bassendine MF; Palmer JM; Heathcote EJ
    Gut; 1994 Feb; 35(2):260-5. PubMed ID: 8307480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.
    Terjung B; Spengler U
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system.
    Tyler KL; Virgin HW; Bassel-Duby R; Fields BN
    J Exp Med; 1989 Sep; 170(3):887-900. PubMed ID: 2549167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An autoantibody profile in primary sclerosing cholangitis.
    Zauli D; Schrumpf E; Crespi C; Cassani F; Fausa O; Aadland E
    J Hepatol; 1987 Aug; 5(1):14-8. PubMed ID: 3498749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice.
    Cuff CF; Lavi E; Cebra CK; Cebra JJ; Rubin DH
    J Virol; 1990 Mar; 64(3):1256-63. PubMed ID: 2154608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making Sense of Autoantibodies in Cholestatic Liver Diseases.
    Marzorati S; Invernizzi P; Lleo A
    Clin Liver Dis; 2016 Feb; 20(1):33-46. PubMed ID: 26593289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis.
    Larson L; James M; Gossard A
    AACN Adv Crit Care; 2016 Oct; 27(4):441-452. PubMed ID: 27959300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association.
    Lawson A; West J; Aithal GP; Logan RF
    Aliment Pharmacol Ther; 2005 Feb; 21(4):401-5. PubMed ID: 15709990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease.
    Pihusch R; Rank A; Göhring P; Pihusch M; Hiller E; Beuers U
    J Hepatol; 2002 Nov; 37(5):548-55. PubMed ID: 12399218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis.
    Roesler KW; Schmider W; Kist M; Batsford S; Schiltz E; Oelke M; Tuczek A; Dettenborn T; Behringer D; Kreisel W
    Dig Dis Sci; 2003 Mar; 48(3):561-9. PubMed ID: 12757171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunofluorescence and electron microscopy study of bovine reovirus multiplication in cell culture].
    Tunkara A; Ignatova M; Vinarova M; Runevski N
    Vet Med Nauki; 1984; 21(3):20-8. PubMed ID: 6330968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
    Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
    J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant forms of cholestatic diseases involving small bile ducts in adults.
    Kim WR; Ludwig J; Lindor KD
    Am J Gastroenterol; 2000 May; 95(5):1130-8. PubMed ID: 10811317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
    Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
    J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions.
    Hosoda H; Okawa-Takatsuji M; Tanaka A; Uwatoko S; Aotsuka S; Hasimoto N; Ozaki Y; Ikeda Y
    Clin Chim Acta; 2004 Apr; 342(1-2):71-81. PubMed ID: 15026266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.